Cardlytics (CDLX) Stock Price

Cardlytics Price

NASDAQ·CLOSED
4.22USD+0.07 (+1.67 %)
Market closed

Over the last 9 years Cardlytics grew revenue by 15.2% annually, reaching 278.30 M USD. For Cardlytics, the net margin of -68.0% is down versus -29.6% a few years ago. The consensus 12-month price target for Cardlytics is 1.53 USD, about 63.7% below where the stock trades today. Of 10 analysts, 0 rate the stock a buy — an overall Hold consensus. The stock trades about 2% above its 52-week low.

Cardlytics stock price

Volume
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Cardlytics over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Cardlytics stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Cardlytics's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Cardlytics Stock Price History
DateCardlytics Price
7/14/20264.22 USD
7/13/20264.15 USD
7/10/20264.32 USD
7/9/20264.16 USD
7/8/20264.14 USD
7/7/20264.26 USD
7/6/20264.54 USD
7/2/20264.47 USD
7/1/20264.44 USD
6/30/20264.49 USD
6/29/20264.87 USD
6/26/20264.71 USD
6/25/20264.97 USD
6/24/20265.36 USD
6/23/20265.34 USD
6/22/20264.95 USD
6/18/20265.20 USD
6/17/20264.99 USD
6/16/20265.24 USD
6/15/20265.36 USD
6/12/20265.41 USD
6/11/20265.12 USD
6/10/20264.83 USD
6/9/20264.76 USD
6/8/20265.20 USD
6/5/20265.98 USD
6/4/20266.10 USD
6/3/20266.50 USD
6/2/20266.52 USD
6/1/20266.77 USD
5/29/20266.75 USD
5/28/20267.13 USD
5/27/20267.14 USD
5/26/20267.21 USD
5/22/20266.93 USD
5/21/20267.29 USD
5/20/20267.25 USD
5/19/20265.96 USD
5/18/20266.06 USD
5/15/20266.32 USD
5/14/20266.47 USD
5/13/20266.65 USD
5/12/20266.75 USD
5/11/20266.51 USD
5/8/20266.40 USD
5/7/20267.82 USD
5/6/20267.95 USD
5/5/20268.39 USD
5/4/20268.80 USD
5/1/20269.15 USD
4/30/20268.97 USD
4/29/20269.00 USD
4/28/20269.05 USD
4/27/20269.01 USD
4/24/20269.30 USD
4/23/20269.70 USD
4/22/20269.90 USD
4/21/20269.72 USD
4/20/202610.20 USD
4/17/202610.10 USD
4/16/20269.52 USD
4/15/202610.10 USD
4/14/20269.66 USD
4/13/20269.80 USD
4/10/20268.96 USD
4/9/20269.69 USD
4/8/202610.50 USD
4/7/202611.50 USD
4/6/202611.80 USD
4/2/202611.30 USD
4/1/202610.00 USD
3/31/202610.50 USD
3/30/20268.99 USD
3/27/20269.32 USD
3/26/202610.10 USD
3/25/202610.60 USD
3/24/20269.39 USD
3/23/20269.12 USD
3/20/20268.25 USD
3/19/20267.59 USD
3/18/20267.25 USD
3/17/20267.30 USD
3/16/20266.97 USD
3/13/20266.75 USD
3/12/20266.69 USD
3/11/20267.03 USD
3/10/20267.04 USD
3/9/20267.38 USD
3/6/20267.80 USD
3/5/20268.16 USD
3/4/20269.00 USD
3/3/20268.29 USD
3/2/20268.28 USD
2/27/20268.64 USD
2/26/20268.81 USD
2/25/20268.82 USD
2/24/20268.68 USD
2/23/20268.55 USD
2/20/20269.08 USD
2/19/20268.86 USD
2/18/20269.31 USD
2/17/20269.11 USD
2/13/20269.33 USD
2/12/202610.10 USD
2/11/20268.87 USD
2/10/20269.31 USD
2/9/20269.34 USD
2/6/20269.06 USD
2/5/20268.65 USD
2/4/20268.37 USD
2/3/20268.82 USD
2/2/20269.42 USD
1/30/20269.69 USD
1/29/202610.20 USD
1/28/202610.30 USD
1/27/202611.10 USD
1/26/202611.50 USD
1/23/202612.10 USD
1/22/202612.00 USD
1/21/202611.70 USD
1/20/202611.50 USD
1/16/202612.00 USD
1/15/202612.40 USD
1/14/202612.90 USD
1/13/202612.20 USD
1/12/202612.90 USD
1/9/202613.50 USD
1/8/202615.20 USD
1/7/202614.30 USD
1/6/202613.10 USD
1/5/202612.40 USD
1/2/202611.20 USD
12/31/202511.50 USD
12/30/202511.50 USD
12/29/202511.60 USD
12/26/202511.85 USD
12/24/202512.20 USD
12/23/202510.80 USD
12/22/202510.30 USD
12/19/202510.30 USD
12/18/202510.10 USD
12/17/20259.62 USD
12/16/202510.60 USD
12/15/202510.40 USD
12/12/202510.80 USD
12/11/202511.70 USD
12/10/202511.80 USD
12/9/202511.90 USD
12/8/202511.00 USD
12/5/202511.00 USD
12/4/202512.10 USD
12/3/202512.30 USD
12/2/202510.80 USD
12/1/202511.90 USD
11/28/202512.40 USD
11/26/202512.30 USD
11/25/202512.00 USD
11/24/202512.20 USD
11/21/202511.40 USD
11/20/202510.90 USD
11/19/202512.10 USD
11/18/202512.30 USD
11/17/202512.70 USD
11/14/202513.90 USD
11/13/202514.40 USD
11/12/202515.00 USD
11/11/202514.70 USD
11/10/202514.30 USD
11/7/202514.10 USD
11/6/202512.60 USD
11/5/202517.60 USD
11/4/202517.35 USD
11/3/202519.00 USD
10/31/202519.40 USD
10/30/202519.00 USD
10/29/202519.40 USD
10/28/202519.90 USD
10/27/202520.70 USD
10/24/202520.30 USD
10/23/202520.70 USD
10/22/202519.20 USD
10/21/202518.90 USD
10/20/202519.50 USD
10/17/202518.80 USD
10/16/202520.00 USD
10/15/202521.50 USD
10/14/202521.20 USD
10/13/202519.30 USD
10/10/202519.10 USD
10/9/202521.40 USD
10/8/202523.20 USD
10/7/202522.75 USD
10/6/202525.80 USD
10/3/202523.70 USD
10/2/202523.70 USD
10/1/202523.60 USD
9/30/202524.30 USD
9/29/202526.40 USD
9/26/202528.20 USD
9/25/202523.80 USD
9/24/202526.40 USD
9/23/202520.90 USD
9/22/202521.50 USD
9/19/202524.30 USD
9/18/202527.55 USD
9/17/202514.30 USD
9/16/202515.30 USD
9/15/202512.70 USD
9/12/202511.20 USD
9/11/202511.50 USD
9/10/20259.36 USD
9/9/20259.80 USD
9/8/20259.10 USD
9/5/20259.32 USD
9/4/20259.21 USD
9/3/20258.90 USD
9/2/202510.10 USD
8/29/202510.20 USD
8/28/202510.60 USD
8/27/202510.30 USD
8/26/202510.30 USD
8/25/202510.90 USD
8/22/202511.10 USD
8/21/202510.10 USD
8/20/202510.50 USD
8/19/202511.00 USD
8/18/202511.25 USD
8/15/202512.10 USD
8/14/202512.10 USD
8/13/202513.10 USD
8/12/202512.50 USD
8/11/202511.00 USD
8/8/202511.80 USD
8/7/202513.00 USD
8/6/202517.60 USD
8/5/202518.40 USD
8/4/202519.60 USD
8/1/202518.80 USD
7/31/202520.40 USD
7/30/202520.50 USD
7/29/202520.80 USD
7/28/202523.50 USD
7/25/202524.50 USD
7/24/202527.05 USD
7/23/202531.20 USD
7/22/202528.50 USD
7/21/202520.30 USD
7/18/202516.80 USD
7/17/202516.80 USD
Access this data via the Eulerpool API

Cardlytics Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
186.90 M USD
-51.60 M USD
-55.40 M USD
Jan 1, 2021
267.10 M USD
-96.40 M USD
-128.60 M USD
Jan 1, 2022
298.50 M USD
-1.20 M USD
-465.30 M USD
Jan 1, 2023
309.20 M USD
-66.92 M USD
-134.70 M USD
Jan 1, 2024
278.30 M USD
-63.74 M USD
-189.30 M USD
Jan 1, 2025 (e)
236.41 M USD
-20.52 M USD
-27.39 M USD
Jan 1, 2026 (e)
223.53 M USD
-8.83 M USD
-17.09 M USD
Jan 1, 2027 (e)
328.24 M USD
0.00 USD
2.76 M USD

Cardlytics Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 17, 2026, 5:54 AM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
20152016201720182019202020212022202320242025e2026e2027e
77.00112.00130.00150.00210.00186.00267.00298.00309.00278.00236.00223.00328.00
45.4516.0715.3840.00-11.4343.5511.613.69-10.03-15.11-5.5147.09
37.6642.8644.6244.0045.2443.5548.3149.3351.1353.9653.9653.9653.96
29.0048.0058.0066.0095.0081.00129.00147.00158.00150.00127.34120.32176.98
-41.00-76.00-25.00-53.00-17.00-55.00-128.00-465.00-134.00-189.00-27.00-17.002.00
85.37-67.11112.00-67.92223.53132.73263.28-71.1841.04-85.71-37.04-111.76
19.5019.5020.0019.1023.7027.2032.2033.4036.4948.3648.3648.3648.36
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Cardlytics generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Cardlytics retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Cardlytics's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Cardlytics has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Cardlytics's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Cardlytics stock margins

The Cardlytics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cardlytics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cardlytics.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
43.61 %
-27.61 %
-29.64 %
Jan 1, 2021
48.56 %
-36.09 %
-48.15 %
Jan 1, 2022
49.25 %
-0.40 %
-155.88 %
Jan 1, 2023
51.30 %
-21.64 %
-43.56 %
Jan 1, 2024
54.09 %
-22.90 %
-68.02 %
Jan 1, 2025 (e)
54.09 %
-8.68 %
-11.58 %
Jan 1, 2026 (e)
54.09 %
-3.95 %
-7.65 %
Jan 1, 2027 (e)
54.09 %
0.00 %
0.84 %

Cardlytics Stock Revenue, EBIT, Earnings per Share

The Cardlytics earnings per share therefore indicates how much revenue Cardlytics has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
6.87 USD
-1.90 USD
-2.04 USD
Jan 1, 2021
8.30 USD
-2.99 USD
-3.99 USD
Jan 1, 2022
8.94 USD
-0.04 USD
-13.93 USD
Jan 1, 2023
8.47 USD
-1.83 USD
-3.69 USD
Jan 1, 2024
5.75 USD
-1.32 USD
-3.91 USD
Jan 1, 2025 (e)
4.37 USD
-0.42 USD
-0.51 USD
Jan 1, 2026 (e)
4.13 USD
-0.18 USD
-0.32 USD
Jan 1, 2027 (e)
6.07 USD
0.00 USD
0.05 USD

Cardlytics business model & stock analysis

Cardlytics Inc is an Atlanta, Georgia-based adtech company that has developed a proprietary online purchase data platform, allowing advertisers to conduct targeted advertising campaigns based on consumer interests and shopping behavior. The company was founded in 2008 by Scott Grimes and Lynne Laube, with the goal of launching the loyalty program "Cardlytics Rewards". The program offered bank customers discounts and rewards for purchases at popular retailers. However, the company quickly shifted its focus to developing its online purchase data platform, which is now the core business of the company. Cardlytics' business model is based on banks (such as Wells Fargo or Bank of America) being able to offer their customers personalized ads based on their shopping behavior. Cardlytics works with these banks to capture and analyze their transaction data without collecting personal identifiable information. The data is then used to provide personalized advertising campaigns across various digital channels (such as mobile apps, email, online advertising). Cardlytics operates in three segments: Bank Partnerships, Direct and Native Advertising, and Analytics and Insights. Bank Partnerships is the largest segment and represents the main revenue source for the company. In this segment, Cardlytics works with over 2,000 banks in the US, as well as in the UK, Australia, and Canada, to provide personalized advertising campaigns for their customers. The Direct and Native Advertising segment of Cardlytics includes partnerships with retailers and brands that advertise on Cardlytics' online purchase data platform. These ads are delivered directly to consumers who have recently shopped at one of the participating retailers. Native advertising includes placements in shopping bags, receipts, and other transaction-related emails. Direct advertising includes ads placed in digital channels such as social media and mobile applications. Cardlytics' Analytics and Insights segment provides insights into consumer shopping behavior. This includes data analytics, reports, and dashboards that give retailers and brands an overview of the effectiveness of their advertising campaigns and help them optimize their advertising strategy. Cardlytics' platform offers several products. One of the main products is purchase data analytics, where the company collects and analyzes transaction data to gain a better understanding of how consumers shop and what products they prefer. Another main product is offering personalized advertising campaigns based on consumer purchase data and interests. Cardlytics also offers a tracking platform that allows advertisers and retailers to track ad performance and return on investment. With this tracking platform, clients can see how their ads are influencing consumers, which consumers are responding to which ads, and how the ad campaign can be optimized to improve results. Overall, Cardlytics has a unique position in the adtech industry, as it can offer personalized advertising based on transaction data. The company has built partnerships with a variety of banks and retailers and offers a wide range of products and services to meet the needs of its clients.

Cardlytics SWOT Analysis

Strengths

Cardlytics Inc has several strengths that contribute to its success in the market. Firstly, the company has developed a unique technology platform that enables it to analyze consumer purchase data from financial institutions. This gives Cardlytics a competitive advantage in understanding consumer behaviors and preferences.

Another strength of Cardlytics is its extensive network of partnerships with major banks and financial institutions. This allows the company to access large amounts of valuable data, further enhancing its ability to provide targeted advertising and insights to its clients.

Additionally, Cardlytics benefits from its strong reputation and established presence in the industry. Its proven track record of delivering results to advertisers and financial institutions builds trust and loyalty among its customers.

Weaknesses

Despite its strengths, Cardlytics Inc also faces some weaknesses that need to be addressed. One weakness is its dependence on its partnership network for data. Any disruptions or termination of these partnerships could significantly impact the company's ability to access and analyze consumer purchase data.

Another weakness is the potential privacy concerns associated with analyzing and utilizing consumer financial data. Cardlytics must ensure it has strong data security measures and maintains compliance with privacy regulations to address these concerns and maintain consumer trust.

Opportunities

Cardlytics Inc has several opportunities for growth and expansion. One opportunity is the increasing demand for personalized advertising and targeted marketing campaigns. As consumers expect more tailored experiences, Cardlytics can capitalize on this trend by utilizing its data analytics capabilities to deliver relevant advertisements to consumers.

Another opportunity lies in expanding its partnerships to reach more financial institutions and markets globally. By forming strategic alliances, Cardlytics can expand its data pool and increase its market reach, opening up new revenue streams.

Threats

There are also threats that Cardlytics Inc needs to consider in its business operations. One threat is the increasing competition in the data analytics and digital advertising industry. As more companies enter the market and offer similar services, Cardlytics must differentiate itself and continuously innovate to maintain its competitive edge.

Additionally, regulatory changes or new privacy laws could pose a threat to Cardlytics' data collection and utilization practices. Adapting to evolving regulations and ensuring compliance will be critical to mitigating this threat and avoiding potential legal and reputational consequences.

Cardlytics Segments

Cardlytics Revenue by Segment (1/5)

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Details
Date
Cost per Served Sales
Cost per Redemption
Bridg Total Revenue
Bridg Subscription Revenue
Cost Other
Bridg Other Revenue
Jan 1, 2018
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2023
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2024
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD

Cardlytics Revenue by Segment (2/5)

  • Max

Cardlytics Direct
Bridg Acquisition
Details
Date
Cardlytics Direct
Bridg Acquisition
Jan 1, 2018
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
Jan 1, 2023
285.43 M USD
23.78 M USD
Jan 1, 2024
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD

Cardlytics Revenue by Segment (3/5)

  • 3 Years

  • 5 Years

  • Max

Cardlytics Direct
Bridg Acquisition
Other Platform Solutions
Details
Date
Cardlytics Direct
Bridg Acquisition
Other Platform Solutions
Jan 1, 2018
149.32 M USD
0.00 USD
1.36 M USD
Jan 1, 2021
258.75 M USD
8.36 M USD
0.00 USD
Jan 1, 2023
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2024
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD
0.00 USD

Cardlytics Revenue by Segment (4/5)

  • Max

Cardlytics Direct
Bridg Acquisition
Details
Date
Cardlytics Direct
Bridg Acquisition
Jan 1, 2018
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
Jan 1, 2023
0.00 USD
0.00 USD
Jan 1, 2024
255.62 M USD
22.68 M USD
Jan 1, 2025
0.00 USD
0.00 USD

Cardlytics Revenue by Segment (5/5)

  • Max

Cardlytics Direct
Bridg Acquisition
Details
Date
Cardlytics Direct
Bridg Acquisition
Jan 1, 2018
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
Jan 1, 2023
0.00 USD
0.00 USD
Jan 1, 2024
0.00 USD
0.00 USD
Jan 1, 2025
212.33 M USD
20.95 M USD

Cardlytics Revenue by Region

  • 3 Years

  • 5 Years

  • Max

United States
United Kingdom
Details
Date
United States
United Kingdom
Jan 1, 2018
131.56 M USD
19.12 M USD
Jan 1, 2021
246.32 M USD
20.80 M USD
Jan 1, 2023
291.42 M USD
17.79 M USD
Jan 1, 2024
254.08 M USD
24.22 M USD
Jan 1, 2025
202.97 M USD
30.30 M USD

Cardlytics Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Cardlytics historical P/E ratio, EBIT multiple, and P/S ratio

Cardlytics annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Cardlytics shares outstanding

The number of shares of Cardlytics was 48.36 M in 2025. This indicates how many shares Cardlytics is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
27.20 M Stocks
Jan 1, 2021
32.20 M Stocks
Jan 1, 2022
33.40 M Stocks
Jan 1, 2023
36.49 M Stocks
Jan 1, 2024
48.36 M Stocks
Jan 1, 2025 (e)
48.36 M Stocks
Jan 1, 2026 (e)
48.36 M Stocks
Jan 1, 2027 (e)
48.36 M Stocks

Current Cardlytics forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy0.00 % (0)
Hold60.00 % (6)
Sell40.00 % (4)
12M Price Target
1.53
Last Price
4.30
Currency
USD
12M Return Potential
-64.42 %
LTM Return
0 %

Cardlytics Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
8/4/2026-1.38USD37.74 MUSD2026 Q2
5/6/2026-0.22USD37.94 MUSD2026 Q1
5/5/2026-0.22USD37.94 MUSD2026 Q1
3/4/2026-0.07USD55.54 MUSD2025 Q4
3/3/2026-0.07USD55.54 MUSD2025 Q4
11/6/20240.03USD87.35 MUSD2024 Q3
5/2/2024-0.24USD67.79 MUSD2024 Q1
2/28/20240.07USD86.40 MUSD2023 Q4
7/31/2023-0.38USD78.63 MUSD2023 Q2
5/1/2023-0.48USD69.85 MUSD2023 Q1

EESG©

Eulerpool ESG Scorecard© for the Cardlytics stock

21/100
3
Environment
28
Social
32
Governance
E

Environment

20
Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees42
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Cardlytics shareholder structure

% Name
9.61537%
CAS Investment Partners, LLC
CAS Investment Partners, LLC
4.47079%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
3.05216%
683 Capital Management LLC
683 Capital Management LLC
2.25459%
KPS Global Asset Management UK Ltd.
KPS Global Asset Management UK Ltd.
2.14204%
Worldly Partners Management, LLC
Worldly Partners Management, LLC
2.13651%
Mirabella Financial Services LLP
Mirabella Financial Services LLP
...

Cardlytics Executives and Management Board

AG

Mr. Amit Gupta

(53)

Chief Executive Officer, Director · since 2023

Compensation4.59 M USD
AD

Ms. Alexis Desieno

(41)

Chief Financial Officer

Compensation2.24 M USD
NL

Mr. Nick Lynton

(42)

Chief Legal and Privacy Officer

Compensation1.71 M USD
AF

Mr. Andre Fernandez

(56)

Independent Director

Compensation173,665.00 USD
JF

Mr. Jon Francis

(53)

Independent Director

Compensation158,665.00 USD

Frequently asked questions about Cardlytics

The business model of Cardlytics Inc revolves around providing a unique advertising platform that allows marketers to reach and engage with targeted consumers through their bank’s digital channels. By partnering with financial institutions, Cardlytics enables advertisers to deliver relevant offers and rewards to consumers based on their purchase behavior and spending patterns. Through its proprietary technology and extensive data insights, Cardlytics helps advertisers optimize their marketing campaigns and drive measurable results. Cardlytics’ business model focuses on generating revenue through advertising and transactional fees.

All fundamentals and in-depth analysis of Cardlytics

Our stock analysis for Cardlytics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cardlytics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.